GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Abstract

The ETS family transcription factor GABPA is suggested as an oncogenic element, which is further supported by the recent reporting of it as the sole ETS member to activate the mutant TERT promoter in thyroid carcinomas (TC). However, it remains unclear how GABPA contributes to TC pathogenesis. The present study is designed to address this issue. TERT expression was significantly diminished in TERT promoter-mutated TC cells upon GABPA inhibition. Surprisingly, GABPA depletion led to robustly increased cellular invasion independently of TERT promoter mutations and TERT expression. DICER1, a component of the microRNA machinery, was identified as a downstream effector of GABPA. GABPA facilitated Dicer1 transcription while its depletion reduced Dicer1 expression. The mutation of the GABPA binding site in the DICER1 promoter led to diminished basal levels of DICER1 promoter activity and abolishment of GABPA-stimulated promoter activity as well. The forced DICER1 expression abrogated the invasiveness of GABPA-depleted TC cells. Consistently, the analyses of 93 patients with papillary thyroid carcinoma (PTC) revealed a positive correlation between GABPA and DICER1 expression. GABPA expression was negatively associated with TERT expression and promoter mutations, in contrast to published observations in cancer cell lines. Lower GABPA expression was associated with distant metastasis and shorter overall/disease-free survival in PTC patients. Similar results were obtained for PTC cases in the TCGA dataset. In addition, a positive correlation between GABPA and DICER1 expression was seen in multiple types of malignancies. Taken together, despite its stimulatory effect on the mutant TERT promoter and telomerase activation, GABPA may itself act as a tumor suppressor rather than an oncogenic factor to inhibit invasion/metastasis in TCs and be a useful predictor for patient outcomes.

Detaljer

Författare
  • Xiaotian Yuan
  • Ninni Mu
  • Na Wang
  • Klas Strååt
  • Anastasios Sofiadis
  • Yanxia Guo
  • Adam Stenman
  • Kailin Li
  • Guanghui Cheng
  • Lu Zhang
  • Feng Kong
  • Lars Ekblad
  • Johan Wennerberg
  • Inga Lena Nilsson
  • C. Christofer Juhlin
  • Catharina Larsson
  • Dawei Xu
Enheter & grupper
Externa organisationer
  • Shandong University
  • Karolinska University Hospital
  • Skåne University Hospital
  • Karolinska Institute
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Medicinsk genetik
  • Cancer och onkologi
Originalspråkengelska
Sidor (från-till)965-979
TidskriftOncogene
Volym38
Utgivningsnummer7
Tidigt onlinedatum2018 sep 4
StatusPublished - 2019
PublikationskategoriForskning
Peer review utfördJa